Alpha Teknova, Inc. (NAS: TKNO) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TKNOAlpha Teknova, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · teknova.com

5.320USD+0.57%Mkt Cap: 285.23M $P/E: —1d ago

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary …

Industry Peers

Drug Manufacturers - Specialty & Generic

$65.19BUSDP/E 23.7

United Therapeutics Corporation

$22.46BUSDP/E 19.5

Neurocrine Biosciences, Inc.

$17.25BUSDP/E 26.4

Swedish Orphan Biovitrum AB (publ)

$15.47BUSDP/E 179.2

$14.18BUSDP/E 29.7

Elanco Animal Health Incorporated

$8.93BUSDP/E 22.7

Hims & Hers Health, Inc.

Lantheus Holdings, Inc.

$6.84BUSDP/E 25.1

Liquidia Corporation

$6.69BUSDP/E 442.8

Amneal Pharmaceuticals, Inc.

$5.76BUSDP/E 48.8

Siegfried Holding AG

$3.65BUSDP/E 19.0

Hikma Pharmaceuticals PLC

$3.55BUSDP/E 11.3

Laboratorios Farmaceuticos Rovi, S.A.

$2.99BUSDP/E 20.9

Supernus Pharmaceuticals, Inc.

$2.52BUSDP/E 56.0

Dermapharm Holding SE

$2.35BUSDP/E 16.3

Prestige Consumer Healthcare Inc.

$2.40BUSDP/E 12.9

BioCryst Pharmaceuticals, Inc.

$1.92BUSDP/E 19.4

Amylyx Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

$1.86BUSDP/E 21.0

PolyPeptide Group AG

Bausch Health Companies Inc.

Faes Farma, S.A.

$1.48BUSDP/E 17.5

Xeris Biopharma Holdings, Inc.

$1.50BUSDP/E 124.1

Phibro Animal Health Corporation

$1.40BUSDP/E 14.8

BioGaia AB (publ)

$1.12BUSDP/E 35.4

Collegium Pharmaceutical, Inc.

$1.18BUSDP/E 17.6

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Cronos Group Inc.

$1.06BUSDP/E Infinity

Eton Pharmaceuticals, Inc.

Pacira BioSciences, Inc.

$1.01BUSDP/E 196.9

BioAge Labs, Inc.

$918.60MUSDP/E 14.7

Pharmanutra S.p.A.

$873.22MUSDP/E 38.1

Amphastar Pharmaceuticals, Inc.

$875.69MUSDP/E 12.0

Esperion Therapeutics, Inc.

$819.46MUSDP/E Infinity

Knight Therapeutics Inc.

$692.84MUSDP/E 161.5

Ironwood Pharmaceuticals, Inc.

$637.05MUSDP/E 6.2

$505.77MUSDP/E 14.3

Aquestive Therapeutics, Inc.

Allergy Therapeutics plc

Canopy Growth Corporation

Emergent BioSolutions Inc.

Akebia Therapeutics, Inc.

Organogenesis Holdings Inc.

Deva Holding A.S.

Antibiotice S.A.

$320.48MUSDP/E 43.7

$294.94MUSDP/E 15.2

Cipher Pharmaceuticals Inc.

$303.08MUSDP/E 9.7

$273.62MUSDP/E 49.1

Animalcare Group plc

$250.29MUSDP/E 47.6

SIGA Technologies, Inc.

$255.34MUSDP/E 12.7

Laboratorio Reig Jofre, S.A.

$236.39MUSDP/E 53.0

Celon Pharma S.A.

$206.95MUSDP/E 10.3

Anika Therapeutics, Inc.

Journey Medical Corporation

Lifecore Biomedical, Inc.

Auxly Cannabis Group Inc.

$182.70MUSDP/E 8.8

Aurora Cannabis Inc.

$143.26MUSDP/E 18.3

Cardiol Therapeutics Inc.

Organigram Global Inc.

$119.66MUSDP/E 18.6

Cumberland Pharmaceuticals Inc.

Vistin Pharma ASA

$83.73MUSDP/E 12.0

HLS Therapeutics Inc.

Shield Therapeutics plc

Nanexa AB (publ)

$62.42MUSDP/E 52.6

ECO Animal Health Group plc

$63.44MUSDP/E 21.8

Orexo AB (publ)

Citius Oncology, Inc.

Cinclus Pharma Holding AB (publ)

Enzymatica AB (publ)

AB Science S.A.

Decibel Cannabis Company Inc.

Moberg Pharma AB (publ)

Turk Ilac Ve Serum Sanayi Anonim Sirketi

Malin Corporation plc

$33.86MUSDP/E Infinity

MediPharm Labs Corp.

BioXcel Therapeutics, Inc.

TherapeuticsMD, Inc.

$23.61MUSDP/E 204.0

Aytu BioPharma, Inc.

Rockwell Medical, Inc.

Rubicon Organics Inc.

Klaria Pharma Holding AB (publ.)

Voyageur Pharmaceuticals Ltd.

Medicon Hellas S.A.

$13.84MUSDP/E 16.8

Biofrontera Inc.

Caring Brands, Inc.

Apimeds Pharmaceuticals US, Inc.

PharmaCielo Ltd.

NUTEX Investments Public Limited Company

$6.05MUSDP/E 3.7

$6.48MUSDP/E 0.3

Sonoma Pharmaceuticals, Inc.

Mercanto Holdings Inc.

$5.46MUSDP/E Infinity

Eagle Pharmaceuticals, Inc.

$3.29MUSDP/E 1.6

Enorama Pharma AB (publ)

Gabather AB (publ)

Shuttle Pharmaceuticals Holdings, Inc.

$2.08MUSDP/E 35.5

CanadaBis Capital Inc.

Genix Pharmaceuticals Corporation

Petros Pharmaceuticals, Inc.

$173.7KUSDP/E 0.0

Clever Leaves Holdings Inc.

Indicators:|

Key Statistics

Company

Market Cap285.23M $

Enterprise Value293.66M $

Revenue (TTM)41.80M $

Gross Profit13.44M $

Net Income (TTM)-17.26M $

Revenue/Share0.7810 USD

Last Price5.320 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees158

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-21.71

PEG—

EV/EBITDA-31.00

EV/Revenue7.03

P/S6.82

P/B4.39

EPS (TTM)-0.31

EPS (Forward)-0.24

52W Range

1.91071% of range6.680

52W High6.680 USD

52W Low1.910 USD

Profitability

Gross Margin33.17%

Oper. Margin-38.80%

EBITDA Margin-22.66%

Profit Margin-42.59%

ROE-25.09%

ROA-16.66%

Growth

Revenue Growth13.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.65M $

CapEx (TTM)1.15M $

FCF Margin-5.71%

FCF Yield-0.84%

Net Debt10.04M $

Net Debt/EBITDA-1.06

Balance Sheet

Debt/Equity0.41

Current Ratio4.59

Quick Ratio3.40

Book Value/Sh1.211 USD

Cash/Share0.3320 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)9.000 USD

Upside (mean)+69.2%

Target Range7.000 USD – 12.00 USD

$7.000+69.2% to mean$12.00

# Analysts3

Ownership

Shares Out.53.61M

Float10.88M

Insiders9.32%

Institutions84.73%

Short Interest

Short Ratio5.0d

Short % Float11.47%

Short % Out.2.33%

Shares Short1.25M

Short (prev mo.)1.11M

Technical

SMA 504.677 (+13.7%)

SMA 2004.010 (+32.7%)

Beta0.63

S&P 52W Chg20.25%

Avg Vol (30d)201.59K

Avg Vol (10d)164.07K

Technical Indicators

RSI (14)54.6

MACD0.2144

MACD Signal0.2888

MACD Hist.-0.0744

BB Upper6.004 USD

BB Middle5.372 USD

BB Lower4.741 USD

BB Width23.50%

ATR (14)0.4158 USD

Vol Ratio (20d)0.36x